论文信息 - Diabetic Ketoacidosis in Patients With COVID-19 - 字舞流文

Diabetic Ketoacidosis in Patients With COVID-19

K. Nugent | Sanjana Rao | M. Rivas | K. Ali

[1] K. Nugent,et al. Analysis of Glucose Levels in Patients Hospitalized With COVID-19 During the First Phase of This Pandemic in West Texas , 2020, Journal of primary care & community health.

[2] R. Pal,et al. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[3] Duc-Huy T. Nguyen,et al. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids , 2020, Cell Stem Cell.

[4] K. Khunti,et al. New-Onset Diabetes in Covid-19 , 2020, The New England journal of medicine.

[5] N. Shehadeh,et al. Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy , 2020, American journal of physiology. Endocrinology and metabolism.

[6] A. Spanevello,et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection , 2020, European Journal of Internal Medicine.

[7] K. Nugent,et al. The Effect of Short‐Term Hyperglycemia on the Innate Immune System , 2016, The American journal of the medical sciences.

[8] J. Lloreta,et al. Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse , 2014, PloS one.